Skip to main content

Fluidized-bed bioartificial liver assist devices (BLADs) based on microencapsulated primary porcine hepatocytes have risk of porcine endogenous retroviruses transmission

Hepatology International volume 4, pages 757–761 (2010)Cite this article

Abstract

Purpose

Bioartificial liver assist devices (BLADs) are expected to bridge liver failure patients to liver transplantation, but porcine endogenous retroviruses (PERVs) still pose a potential risk in pig-to-human xenotransplantation and thereby limit the use of bioartificial liver therapy. In our lab, fluidized-bed BLADs based on microencapsulated primary porcine hepatocytes have been successfully used to treat liver failure pigs. We detected the risk of PERVs transmission of microencapsulated primary porcine hepatocytes—the key component of fluidized-bed BLADs, to evaluate the biosafety of this device for further clinical applications.

Methods

Microencapsulated primary porcine hepatocytes (cell diameter = 300 μm) were cultured in Dulbecco’s modified Eagles medium (DMEM). Microencapsulated cell culture supernatants were collected at 6, 12, 24 and 72 h. HEK-293 were cocultured with these supernatants, and the cocultured cells were harvested every 7 days. RT-PCR was used to detect PERVs transmission. RT-qPCR was used to get the number of virus copies. PK-15 was used as the positive control whereas HepG2 was used as the negative control.

Results

PERV was detected in all supernatants, and the viral load of the supernatants increased with time. Moreover, cocultured 293 cells were positive for PERV-specific sequences.

Conclusion

The kind of fluidized-bed BLADs based on microencapsulated primary porcine hepatocytes have risk of PERVs transmission. Further extensive pre-clinical study focused on biosafety is warranted.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

References

  1. van de Kerkhove MP, Hoekstra R, Chamuleau R, van Gulik TM. Clinical application of bioartificial liver support systems. Ann Surg 2004;240:216–230

    Article  PubMed  Google Scholar 

  2. Naruse K, Tang W, Makuuchi M. Artificial and bioartificial liver support: a review of perfusion treatment for hepatic failure patients. World J Gastroenterol 2007;13:1516–1521

    PubMed  Google Scholar 

  3. McKenzie TJ, Lillegard JB, Nyberg SL. Artificial and bioartificlal liver support. Semin Liver Dis 2008;28:210–217

    Article  PubMed  Google Scholar 

  4. Ellis AJ, Hughes RD, Wendon JA, Dunne J, Langley PG, Kelly JH, Gislason GT, Sussman NL, Williams R. Pilot-controlled trial of the extracorporeal liver assist device in acute liver failure. Hepatology 1996;24:1446–1451

    CAS  Article  PubMed  Google Scholar 

  5. Watanabe FD, Mullon CJP, Hewitt WR, Arkadopoulos N, Kahaku E, Eguchi S, Khalili T, Arnaout W, Shackleton CR, Rozga J, Solomon B, Demetriou AA. Clinical experience with a bioartificial liver in the treatment of severe liver failure—a phase I clinical trial. Ann Surg 1997;225:484–491

    CAS  Article  PubMed  Google Scholar 

  6. Sauer IM, Zeilinger K, Obermayer N, Pless G, Grunwald A, Pascher A, Mieder T, Roth S, Goetz M, Kardassis D, Mas A, Neuhaus P, Gerlach JC. Primary human liver cells as source for modular extracorporeal liver support—a preliminary report. Int J Artif Organs 2002;25:1001–1005

    CAS  PubMed  Google Scholar 

  7. Mazariegos GV, Kramer DJ, Lopez RC, Shakil AO, Rosenbloom AJ, DeVera M, Giraldo M, Grogan TA, Zhu Y, Fulmer ML, Amiot BP, Patzer JF. Safety observations in Phase I clinical evaluation of the Excorp Medical Bioartificial Liver Support System after the first four patients. ASAIO J 2001;47:471–475

    CAS  Article  PubMed  Google Scholar 

  8. Gao Y, Xu J, Sun B, Jiang H-C. Microencapsulated hepatocytes and islets as in vivo bioartificial liver support system. World J Gastroenterol 2004;10:2067–2071

    CAS  PubMed  Google Scholar 

  9. Diekmann S, Glockner P, Mittag A, Tarnok A, Bader A. Encapsulated hepatocytes for the application in a bioartificial liver support system. Cytometry A 2007;71A:516–517

    Google Scholar 

  10. Kinasiewicz A, Gautier A, Lewinska D, Bukowski J, Legallais C, Werynski A. Culture of C3A cells in alginate beads for fluidized bed bioartificial liver. Transplant Proc 2007;39:2911–2913

    CAS  Article  PubMed  Google Scholar 

  11. Kinasiewicz A, Gautier A, Smietanka A, Legallais C, Werynski A. Encapsulation of hepatic cells in alginate beads for fluidized bed bioartificial liver. Studies on chitosan membrane. Int J Artif Organs 2008;31:655–657

    Google Scholar 

  12. Dore E, Legallais C. A new concept of bioartificial liver based on a fluidized bed bioreactor. Ther Apher 1999;3:264–267

    CAS  Article  PubMed  Google Scholar 

  13. Hwang YJ, Kim YI, Lee JG, Lee JW, Kim JW, Chung JM. Development of bioartificial liver system using a fluidized-bed bioreactor. Transplant Proc 2000;32:2349–2351

    CAS  Article  PubMed  Google Scholar 

  14. David B, Dore E, Jaffrin MY, Legallais C. Mass transfers in a fluidized bed bioreactor using alginate beads for a future bioartificial liver. Int J Artif Organs 2004;27:284–293

    CAS  PubMed  Google Scholar 

  15. Carpentier B, Gautier A, Paullier R, Legallais C. Mass transfer studies in a model of fluidized bed bioartificial liver. Int J Artif Organs 2006;29:509–512

    Google Scholar 

  16. Kinasiewicz A, Gautier A, Lewinska D, Dufresne M, Paullier P, Bukowski J, Legallais C, Werynski A. Activity of cells within alginate beads produced for fluidized bed bioreactor (bioartificial liver). Int J Artif Organs 2006;29:519–521

    Google Scholar 

  17. Hwang YJ, Chang SK, Kim JY, Kim SG, Yun YG, Il Kim Y. Bioartificial liver system using a fluidized-bed bioreactor. Liver Transpl 2008;14:S188–191

    Article  Google Scholar 

  18. Patience C, Takeuchi Y, Weiss RA. Infection of human cells by an endogenous retrovirus of pigs. Nat Med 1997;3:282–286

    CAS  Article  PubMed  Google Scholar 

  19. Ritzhaupt A, van der Laan LJW, Salomon DR, Wilson CA. Porcine endogenous retrovirus infects but does not replicate in nonhuman primate primary cells and cell lines. J Virol 2002;76:11312–11320

    CAS  Article  PubMed  Google Scholar 

  20. Bartosch B, Stefanidis D, Myers R, Weiss R, Patience C, Takeuchi Y. Evidence and consequence of porcine endogenous retrovirus recombination. J Virol 2004;78:13880–11390

    CAS  Article  PubMed  Google Scholar 

  21. Machnik G, Sypniewski D, Mazurek U, Rozek-Kostorkiewicz J, Wilczok T. Hazards of porcine endogenous retroviruses (PERVs) in xenotransplantation. Med Weter 2004;60:345–348

    Google Scholar 

  22. Denner J. Recombinant porcine endogenous retroviruses (PERV-A/C): a new risk for xenotransplantation? Arch Virol 2008;153:1421–1426

    CAS  Article  PubMed  Google Scholar 

  23. Denner J, Schuurman HJ, Patience C. Strategies to prevent transmission of porcine endogenous retroviruses, Chap. 5. In The International Xenotransplantation Association Consensus Statement On Conditions for Undertaking Clinical Trials of Porcine Islet Products in Type 1 Diabetes. Xenotransplantation 2009; 16:239–248

    Google Scholar 

  24. Fruhauf JH, Mertsching H, Giri S, Fruhauf NR, Bader A. Porcine endogenous retrovirus released by a bioartificial liver infects primary human cells. Liver Int 2009;29:1553–1561

    Article  PubMed  Google Scholar 

  25. Yu CB, Lv GL, Pan XP, Chen YS, Cao HC, Zhang YM, Du WB, Yang SG, Li LJ. In vitro large-scale cultivation and evaluation of microencapsulated immortalized human hepatocytes (HepLL) in roller bottles. Int J Artif Organs 2009;32:272–281

    CAS  PubMed  Google Scholar 

  26. Switzer WM, Shanmugam V, Heneine W. Polymerase chain reaction assays for the diagnosis of infection with the porcine endogenous retrovirus and the detection of pig cells in human and nonhuman recipients of pig xenografts. Transplantation 1999;68:183–188

    CAS  Article  PubMed  Google Scholar 

  27. Lanza RP, Hayes JL, Chick WL. Encapsulated cell technology. Nat Biotechnol 1996;14:1107–1111

    CAS  Article  PubMed  Google Scholar 

  28. Aoki K, Hakamada K, Seino K, Umehara Y, Itabashi Y, Sasaki M. Development of a bioartificial liver using microencapsulated xenohepatocytes. New Directions for Cellular and Organ Transplantation, vol 1210. 2000. p. 55–59

  29. Kendall WF, Collins BH, Opara EC. Islet cell transplantation for the treatment of diabetes mellitus. Expert Opin Biol Ther 2001;1:109–119

    CAS  Article  PubMed  Google Scholar 

  30. Lim GJ, Zare S, Van Dyke M, Atala A. Cell Microencapsulation. In Therapeutic Applications of Cell Microencapsulation, vol 670. 2010. p. 126–136

Download references

Conflict of interest

This material is based upon work funded by Zhejiang Provincial Natural Science Foundation of China under Grant No. Y206005 and Zhejiang Provincial Science Foundation of China under Grant No. 2007C23009.

Author information

Affiliations

  1. The First Affiliated Hospital, College of Medicine, Zhejiang University, No.79 Qingchun Road, Hangzhou, 310003, China

    Qian Yang, Fei Liu, Xiao Ping Pan, GuoLiang Lv, AnYe Zhang, Chen Bo Yu & LanJuan Li

Authors
  1. Qian Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Fei Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Xiao Ping Pan
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. GuoLiang Lv
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. AnYe Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Chen Bo Yu
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. LanJuan Li
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to LanJuan Li.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Yang, Q., Liu, F., Pan, X.P. et al. Fluidized-bed bioartificial liver assist devices (BLADs) based on microencapsulated primary porcine hepatocytes have risk of porcine endogenous retroviruses transmission. Hepatol Int 4, 757–761 (2010). https://doi.org/10.1007/s12072-010-9210-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12072-010-9210-6

Keywords

  • Microencapsulated primary porcine hepatocytes
  • Bioartificial liver assist devices
  • Porcine endogenous retroviruses
  • RT-PCR
  • RT-qPCR